Skip to main content

Bristol-Myers Squibb Company(BMY-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume
Day Low57.81
Day High58.42
Open:58.01
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Reports for Bristol-Myers Squibb Company

News for Bristol-Myers Squibb Company

Select a category then submit the form to load news
MarketBeat
Argenx's 28% Surge & Promising Product Propel Investor Confidence
Motley Fool
3 Artificial Intelligence (AI) Stocks That Could Soar More Than Nvidia, According to Wall Street
Barchart
Should You Follow Warren Buffett's Lead and Sell HPQ Stock?
PR Newswire
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance
Motley Fool
2 Undervalued Dividend Stocks to Buy Now
The Globe and Mail
A U.S. investment strategy for market uncertainty
Motley Fool
3 No-Brainer Dividend Stocks to Buy in September
Motley Fool
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
MarketBeat
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
Motley Fool
What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?
PR Newswire
Cellares Announces Bristol Myers Squibb has Joined Technology Adoption Partnership Program to Evaluate Automated Manufacturing of CAR-T Cell Therapy on the Cell Shuttle Platform
Motley Fool
Is Alexandria Real Estate Equities a Buy?
Motley Fool
2 Dividend Stocks to Buy Hand Over Fist
Motley Fool
2 Blue Chip Dividend Stocks That Are Top Buys in August
MarketBeat
3 Pharmaceutical Stocks to Buy and Hold for the Long Haul
Motley Fool
Should Dividend Investors Buy Bristol Myers Stock?
MarketBeat
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
MarketBeat
2 Attractive Large Caps on Sale After Q2 Earnings
Motley Fool
Bristol Myers Squibb (BMY) Q2 2023 Earnings Call Transcript
Motley Fool
2 Dirt Cheap Dividend Stocks to Buy Right Now
Barchart
Markets Today: Stocks Soar on the Outlook for a Soft Landing
MarketBeat
Exscientia is the Sniper of the AI Drug Discovery Industry
Barchart
Stocks Climb Before the Open as Investors Await Key U.S. GDP Data, Meta Results Boost Sentiment
Motley Fool
2 Cheap High-Yield Dividend Stocks to Buy Now
MarketBeat
Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus
GlobeNewswire
Arbutus Appoints Two New Executives
Motley Fool
3 Spectacular Dividend Stocks to Buy in July
The Globe and Mail
11 U.S. stocks to seize the underperformance of the Health Care sector
Motley Fool
Why Aurinia Pharmaceuticals Stock Is Marching Higher Friday
Motley Fool
5 High-Yielding Dividend Stocks That Are Bargain Buys
Motley Fool
2 Low-Priced Stocks That Could Make You Richer
Motley Fool
3 Healthcare Stocks That Are Too Cheap to Ignore
More Bristol-Myers Squibb Company news

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2023 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.